IBDEI1PH ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28548,1,4,0)
 ;;=4^R97.0
 ;;^UTILITY(U,$J,358.3,28548,2)
 ;;=^5019746
 ;;^UTILITY(U,$J,358.3,28549,0)
 ;;=R97.1^^132^1332^66
 ;;^UTILITY(U,$J,358.3,28549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28549,1,3,0)
 ;;=3^Elevated Cancer Antigen 125
 ;;^UTILITY(U,$J,358.3,28549,1,4,0)
 ;;=4^R97.1
 ;;^UTILITY(U,$J,358.3,28549,2)
 ;;=^5019747
 ;;^UTILITY(U,$J,358.3,28550,0)
 ;;=R97.2^^132^1332^68
 ;;^UTILITY(U,$J,358.3,28550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28550,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,28550,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,28550,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,28551,0)
 ;;=R97.8^^132^1332^22
 ;;^UTILITY(U,$J,358.3,28551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28551,1,3,0)
 ;;=3^Abnormal Tumor Markers NEC
 ;;^UTILITY(U,$J,358.3,28551,1,4,0)
 ;;=4^R97.8
 ;;^UTILITY(U,$J,358.3,28551,2)
 ;;=^5019749
 ;;^UTILITY(U,$J,358.3,28552,0)
 ;;=R93.8^^132^1332^12
 ;;^UTILITY(U,$J,358.3,28552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28552,1,3,0)
 ;;=3^Abnormal Findings on Dx Imaging of Body Structures
 ;;^UTILITY(U,$J,358.3,28552,1,4,0)
 ;;=4^R93.8
 ;;^UTILITY(U,$J,358.3,28552,2)
 ;;=^5019721
 ;;^UTILITY(U,$J,358.3,28553,0)
 ;;=R93.1^^132^1332^14
 ;;^UTILITY(U,$J,358.3,28553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28553,1,3,0)
 ;;=3^Abnormal Findings on Dx Imaging of Heart/Cor Circ
 ;;^UTILITY(U,$J,358.3,28553,1,4,0)
 ;;=4^R93.1
 ;;^UTILITY(U,$J,358.3,28553,2)
 ;;=^5019714
 ;;^UTILITY(U,$J,358.3,28554,0)
 ;;=R68.83^^132^1332^48
 ;;^UTILITY(U,$J,358.3,28554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28554,1,3,0)
 ;;=3^Chills w/o Fever
 ;;^UTILITY(U,$J,358.3,28554,1,4,0)
 ;;=4^R68.83
 ;;^UTILITY(U,$J,358.3,28554,2)
 ;;=^5019555
 ;;^UTILITY(U,$J,358.3,28555,0)
 ;;=R68.2^^132^1332^62
 ;;^UTILITY(U,$J,358.3,28555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28555,1,3,0)
 ;;=3^Dry Mouth,Unspec
 ;;^UTILITY(U,$J,358.3,28555,1,4,0)
 ;;=4^R68.2
 ;;^UTILITY(U,$J,358.3,28555,2)
 ;;=^5019552
 ;;^UTILITY(U,$J,358.3,28556,0)
 ;;=R09.02^^132^1332^88
 ;;^UTILITY(U,$J,358.3,28556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28556,1,3,0)
 ;;=3^Hypoxemia
 ;;^UTILITY(U,$J,358.3,28556,1,4,0)
 ;;=4^R09.02
 ;;^UTILITY(U,$J,358.3,28556,2)
 ;;=^332831
 ;;^UTILITY(U,$J,358.3,28557,0)
 ;;=R39.81^^132^1332^92
 ;;^UTILITY(U,$J,358.3,28557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28557,1,3,0)
 ;;=3^Incontinence d/t Cognitive Imprmt/Svr Disability/Mobility
 ;;^UTILITY(U,$J,358.3,28557,1,4,0)
 ;;=4^R39.81
 ;;^UTILITY(U,$J,358.3,28557,2)
 ;;=^5019349
 ;;^UTILITY(U,$J,358.3,28558,0)
 ;;=R29.6^^132^1332^146
 ;;^UTILITY(U,$J,358.3,28558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28558,1,3,0)
 ;;=3^Repeated Falls
 ;;^UTILITY(U,$J,358.3,28558,1,4,0)
 ;;=4^R29.6
 ;;^UTILITY(U,$J,358.3,28558,2)
 ;;=^5019317
 ;;^UTILITY(U,$J,358.3,28559,0)
 ;;=R44.1^^132^1332^160
 ;;^UTILITY(U,$J,358.3,28559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28559,1,3,0)
 ;;=3^Visual Hallucinations
 ;;^UTILITY(U,$J,358.3,28559,1,4,0)
 ;;=4^R44.1
 ;;^UTILITY(U,$J,358.3,28559,2)
 ;;=^5019456
 ;;^UTILITY(U,$J,358.3,28560,0)
 ;;=S43.51XA^^132^1333^12
 ;;^UTILITY(U,$J,358.3,28560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28560,1,3,0)
 ;;=3^Sprain of Right Acromioclavicular Joint
 ;;^UTILITY(U,$J,358.3,28560,1,4,0)
 ;;=4^S43.51XA
 ;;^UTILITY(U,$J,358.3,28560,2)
 ;;=^5027903
 ;;^UTILITY(U,$J,358.3,28561,0)
 ;;=S43.52XA^^132^1333^1
 ;;^UTILITY(U,$J,358.3,28561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28561,1,3,0)
 ;;=3^Sprain of Left Acromioclavicular Joint
 ;;^UTILITY(U,$J,358.3,28561,1,4,0)
 ;;=4^S43.52XA
